Pansib, Bb Boy S.

HRN: 21-26-92  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2022
AMPICILLIN 250MG (VIAL)
06/25/2022
07/01/2022
IV
105mg
Q12Hrs
Tc Neonatal Pneumonia
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: